Susquehanna International Group, LLP Becton Dickinson & CO Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Susquehanna International Group, LLP holds 62,231 shares of BDX stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,231

Previous 131,282 52.6%

Holding current value

$14.1 Million

Previous $30.7 Million 51.1%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $15.3 Million - $16.7 Million	-69,051 Reduced 52.6%	62,231 $15 Million
Q2 2024 Aug 15, 2024	BUY	$225.07 - $246.17 $7.84 Million - $8.57 Million	34,813 Added 36.09%	131,282 $30.7 Million
Q1 2024 May 07, 2024	BUY	$233.45 - $247.73 $2.09 Million - $2.22 Million	8,972 Added 10.25%	96,469 $23.9 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $5.14 Million - $5.91 Million	-22,120 Reduced 20.18%	87,497 $21.3 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $8.39 Million - $9.34 Million	32,921 Added 42.92%	109,617 $28.3 Million
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $16.5 Million - $18.4 Million	-69,235 Reduced 47.44%	76,696 $20.2 Million
Q1 2023 May 16, 2023	BUY	$229.71 - $259.35 $569,221 - $642,669	2,478 Added 1.73%	145,931 $36.1 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $26.9 Million - $31.6 Million	123,082 Added 604.2%	143,453 $36.5 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $1.13 Million - $5.87 Million	-22,202 Reduced 52.15%	20,371 $4.54 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $7.86 Million - $9.22 Million	-33,494 Reduced 44.03%	42,573 $10.5 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $3.2 Million - $3.55 Million	13,127 Added 20.86%	76,067 $20.2 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $2.21 Million - $2.41 Million	9,595 Added 17.99%	62,940 $15.8 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $12.5 Million - $13.8 Million	-53,875 Reduced 50.25%	53,345 $13.1 Million
Q2 2021 Aug 11, 2021	BUY	$232.65 - $254.58 $16.3 Million - $17.8 Million	69,936 Added 187.58%	107,220 $26.1 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $10.7 Million - $11.9 Million	-46,302 Reduced 55.39%	37,284 $9.07 Million
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $8.96 Million - $9.93 Million	-40,373 Reduced 32.57%	83,586 $20.9 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $24.5 Million - $31.4 Million	113,393 Added 1073.19%	123,959 $28.8 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $2 Million - $2.4 Million	9,101 Added 621.23%	10,566 $2.53 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $12.7 Million - $18.2 Million	-65,060 Reduced 97.8%	1,465 $337,000
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $15.3 Million - $17.3 Million	64,866 Added 3909.95%	66,525 $18.1 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $706,266 - $784,373	-3,063 Reduced 64.87%	1,659 $420,000
Q2 2019 Aug 16, 2019	BUY	$217.4 - $246.08 $559,152 - $632,917	2,572 Added 119.63%	4,722 $1.19 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $425,234 - $481,332	-1,956 Reduced 47.64%	2,150 $542,000
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $158,364 - $177,959	761 Added 22.75%	4,106 $984,000
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $335,516 - $392,360	1,633 Added 95.39%	3,345 $725,000
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $430,164 - $506,728	-2,276 Reduced 57.07%	1,712 $366,000
Q3 2017 Nov 20, 2017	BUY	$186.89 - $198.9 $745,317 - $793,213	3,988	3,988 $781,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Becton Dickinson & CO Transaction History